Cite
HARVARD Citation
Chan, A. et al. (n.d.). Phase II, open‐label trial of lapatinib and vinorelbine in women with previously treated HER2‐positive metastatic breast cancer. Asia-Pacific journal of clinical oncology. 10 (4), pp. 368-375. [Online].